As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...
Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its ...
Everyday Health on MSN
How the new oral GLP-1 weight loss medications work
Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.
Real Housewives star Heather Gay shares why 30-pound weight loss with GLP-1 is a ‘miracle’ - The reality star started using ...
MedPage Today on MSN
Menopause Hormone Therapy May Boost GLP-1 Drug Benefits
Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
News Medical on MSN
New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders
By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...
The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.
Sally Lyons Wyatt, from Data analytics company Circana, says GLP-1 potential users are only three percent more likely to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results